Autolus Therapeutics
Developing T cell therapies
- B2B
About Autolus Therapeutics
Clinical-stage biopharmaceutical company developing next-generation T cell therapies for cancer treatment by engineering targeted and active therapies to eliminate cancer cells
Key facts
- Industry
- Biotechnology
- Company size
- 251–1,000 employees
- Headquarters
- London, England, United Kingdom
- Founded
- 2014
- Revenue
- $75.4MFY2025, publicly reported
- Website
- autolus.com
Autolus Therapeutics at a glance
Autolus Therapeutics is a B2B company in the Biotechnology industry, headquartered in London, England, United Kingdom.
Autolus Therapeutics was founded in 2014.
Autolus Therapeutics has 251–1,000 employees.
Autolus Therapeutics's revenue is $75.4M (FY2025, publicly reported).
Frequently asked questions about Autolus Therapeutics
What is Autolus Therapeutics's revenue?
Autolus Therapeutics's revenue is $75.4M (FY2025, publicly reported).
How many employees does Autolus Therapeutics have?
Autolus Therapeutics has 251–1,000 employees.
Where is Autolus Therapeutics headquartered?
Autolus Therapeutics is headquartered in London, England, United Kingdom.
Selling to companies like Autolus Therapeutics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies